Babuta M, Furi I, Bala S, Bukong TN, Lowe P, Catalano D, et al
The therapeutic reach of GLP-1 RAs is currently undergoing an "Indication Land Grab." As clinical data accumulates, these molecules are being explored across multiple organ systems, driven by their ability to modulate inflammation, mitochondrial efficiency, and metabolic signaling
Planned medical or surgical procedures if you are due to undergo surgery or an invasive procedure, inform both your trial team and the anaesthetic or surgical team
MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
In its clinical trials, patients lost an average of 5% to 10% of their body weight
How can I prevent retatrutide injection site reactions